Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2020	Mar. 31, 2020
Current assets:
Cash and cash equivalents	$ 4,426,836	$ 751,942
Accounts receivable, net	3,380,237	3,405,341
Advances to vendor	1,022,607
Inventories, net	10,878,423	6,185,102
Prepaid expenses and other current assets	4,664,638	3,691,990
Total current assets	24,372,741	14,034,375
Advances and receivables - related parties	5,862,432	5,060,370
Property and equipment, net	24,261,728	19,769,152
Intangible assets, net	4,295,029	900,005
Security deposits	1,264,352	1,264,353
Right of use assets-lease	58,408,630	57,587,790
Deferred income taxes	643,116	643,116
Goodwill	2,240,798
Total assets	121,348,826	99,259,161
Current liabilities:
Accounts payable	8,996,800	10,674,455
Deferred revenue	2,786,642	1,311,228
Borrowings against lines of credit, current,net	20,141,297	20,141,297
Notes payable, current	76,068	77,903
Finance lease obligations, current	133,733	137,243
Accrued expenses	1,679,214	1,307,069
Operating lease liabilities, current	5,441,020	5,438,356
Other payables, current	4,225,834	3,584,756
Total current liabilities	43,480,608	42,672,307
Notes payable, non-current	29,550	46,706
Finance lease obligations, non-current	245,314	277,350
PPP Loans from government	1,768,212
Other payables, non-current	83,102	83,102
Deferred tax liability	1,083,763
Long term operating lease liabilities	59,546,344	58,729,843
Total liabilities	106,236,893	101,809,308
Commitments and contingencies
Equity (deficiency)
Common stock, $0.0001 par value; 100,000,000 shares authorized, 25,194,086 and 18,658,547 shares issued and outstanding as of June 30, 2020 and March 31, respectively	3,945	1,866
Additional paid-in capital	26,754,480	18,202,323
Accumulated deficit	(20,650,949)	(24,254,336)
Accumulated other comprehensive income	21,560
Total stockholders’ equity (deficiency) attributable to iFresh	14,537,575	(2,550,147)
Noncontrolling interest	574,358
Total equity (deficiency)	15,111,933	(2,550,147)
Total liabilities and equity (deficiency)	121,348,826	99,259,161
Series A Preferred shares
Equity (deficiency)
Preferred stock value	3,500,000	3,500,000
Series B Preferred shares
Equity (deficiency)
Preferred stock value	$ 4,908,539